Methazolamide is a sulfonamide derivative and a potent carbonic anhydrase inhibitor primarily used to treat glaucoma by reducing intraocular pressure through the suppression of aqueous humor. Laboratories… Read more













![Chemical structure of N-[5-{[5-(Acetylimino)-4-methyl-4,5-dihydro-1,3,4-thiadiazole-2-sulfonamido]sulfonyl}-3-methyl-2,3-dihydro-1,3,4-thiadiazol-2-ylidene]acetamide triethylamine salt](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2FN-5-5-Acetylimino-4-methyl-45-dihydro-134-thiadiazole-2-sulfonamidosulfonyl-3-methyl-23-dihydro-134-thiadiazol-2-ylideneacetamide-triethylamine-salt.png&w=3840&q=75)
Methazolamide is a sulfonamide derivative and a potent carbonic anhydrase inhibitor primarily used to treat glaucoma by reducing intraocular pressure through the suppression of aqueous humor. Laboratories rely on high-quality reference standards of this compound to ensure accurate analysis and regulatory compliance. This category provides a comprehensive selection of essential materials, including pharmacopeial and non-pharmacopeial impurities, metabolites like 5-imino-4-methyl-1,3,4-thiadiazole-2-sulfonamide, and stable isotope labelled compounds such as methazolamide-d3 and methazolamide-d6. These analytical standards are critical tools for rigorous impurity profiling, method validation, and ongoing quality control in pharmaceutical research. By utilizing these precise chemical references, analytical chemists can effectively identify unknown peaks, quantify degradation products, and maintain the integrity of their assay methods throughout the drug development and manufacturing lifecycle.